Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 926.93 MM.
- The operating income for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 180.63 MM.
- The net income for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 182.97 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 926.93 | 180.63 | 182.97 |
2025-03-31 | 904.04 | 182.63 | 183.61 |
2024-12-31 | 881.16 | 184.63 | 184.25 |
2024-09-30 | 885.83 | 151.17 | 159.18 |
2024-06-30 | 839.00 | 181.31 | 171.64 |
2024-03-31 | 895.55 | 157.32 | 147.96 |
2023-12-31 | 841.54 | 160.64 | 148.21 |
2023-09-30 | 841.01 | 199.75 | 222.20 |
2023-06-30 | 859.93 | 173.09 | 197.16 |
2023-03-31 | 790.76 | 185.36 | 212.34 |
2022-12-31 | 841.59 | 158.00 | 193.56 |
2022-09-30 | 825.21 | 145.84 | 150.97 |
2022-06-30 | 781.42 | 169.98 | 171.56 |
2022-03-31 | 750.10 | 156.77 | 156.79 |
2021-12-31 | 705.46 | 140.63 | 143.28 |
2021-09-30 | 655.44 | 134.46 | 140.50 |
2021-06-30 | 637.93 | 115.28 | 123.85 |
2021-03-31 | 641.02 | 121.19 | 132.80 |
2020-12-31 | 622.25 | 114.43 | 126.56 |
2020-09-30 | 614.30 | 146.62 | 139.65 |
2020-06-30 | |||
2020-03-31 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | 0.31 | 0.31 |
2024-03-31 | 0.26 | 0.26 |
2023-12-31 | 0.26 | |
2023-09-30 | 0.40 | 0.40 |
2023-06-30 | 0.35 | 0.35 |
2023-03-31 | 0.38 | 0.38 |
2022-12-31 | 0.35 | |
2022-09-30 | 0.27 | 0.27 |
2022-06-30 | 0.31 | 0.31 |
2022-03-31 | 0.28 | 0.28 |
2021-12-31 | 0.26 | |
2021-09-30 | 0.25 | 0.25 |
2021-06-30 | 0.22 | 0.22 |
2021-03-31 | 0.24 | 0.24 |
2020-12-31 | 0.23 | |
2020-09-30 | 0.25 | 0.25 |
2020-06-30 | 0.26 | 0.26 |
2020-03-31 | 0.26 | 0.26 |
Cash Flow: Operations, Investing, Financing
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | 219.65 | -310.93 | -25.01 |
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | 315.95 | 109.04 | -186.45 |
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | 203.99 | -117.97 | -27.71 |
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | 215.09 | -160.61 | -25.20 |
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | 151.23 | -244.85 | -17.75 |
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | 0.00 | 0.51 |
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Management Effectiveness
- The roa for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 0.08.
- The roe for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 0.12.
- The roic for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 0.11.
- The croic for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is -0.07.
- The ocroic for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 0.13.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.08 | 0.12 | 0.11 | -0.07 | 0.13 |
2025-03-31 | 0.00 | 0.00 | |||
2024-12-31 | 0.07 | 0.12 | 0.10 | 0.00 | 0.00 |
2024-09-30 | 0.07 | 0.10 | 0.10 | 0.14 | 0.19 |
2024-06-30 | 0.06 | 0.09 | 0.09 | 0.15 | 0.20 |
2024-03-31 | 0.09 | 0.09 | 0.15 | 0.20 | |
2023-12-31 | 0.10 | 0.15 | 0.14 | 0.00 | 0.00 |
2023-09-30 | 0.09 | 0.13 | 0.12 | 0.00 | 0.00 |
2023-06-30 | 0.10 | 0.13 | 0.12 | 0.00 | 0.00 |
2023-03-31 | 0.15 | 0.13 | 0.00 | 0.00 | |
2022-12-31 | 0.08 | 0.11 | 0.10 | 0.00 | 0.00 |
2022-09-30 | 0.09 | 0.11 | 0.10 | 0.00 | 0.00 |
2022-06-30 | 0.08 | 0.12 | 0.11 | 0.00 | 0.00 |
2022-03-31 | 0.08 | 0.12 | 0.11 | 0.00 | 0.00 |
2021-12-31 | 0.08 | 0.11 | 0.10 | 0.02 | 0.00 |
2021-09-30 | 0.08 | 0.11 | 0.10 | 0.00 | 0.00 |
2021-06-30 | 0.07 | 0.10 | 0.09 | -0.08 | 0.11 |
2021-03-31 | 0.08 | 0.11 | 0.10 | -0.08 | 0.11 |
2020-12-31 | 0.08 | 0.10 | 0.09 | -0.08 | 0.11 |
2020-09-30 | 0.09 | 0.12 | 0.11 | 0.00 | 0.00 |
2020-06-30 | 0.09 | 0.12 | 0.11 | -0.02 | 0.10 |
2020-03-31 | 0.09 | 0.13 | 0.12 | -0.02 | 0.11 |
Gross Margins
- The gross margin for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 0.78.
- The net margin for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 0.21.
- The operating margin for Jilin Province Huinan Changlong Bio-pharmacy Company Limited as of 30 June 2025 is 0.21.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.78 | 0.21 | 0.21 |
2025-03-31 | |||
2024-12-31 | 0.75 | 0.20 | 0.22 |
2024-09-30 | 0.75 | 0.20 | 0.22 |
2024-06-30 | 0.69 | 0.18 | 0.19 |
2024-03-31 | 0.69 | 0.18 | 0.19 |
2023-12-31 | 0.70 | 0.26 | 0.24 |
2023-09-30 | 0.72 | 0.23 | 0.20 |
2023-06-30 | 0.74 | 0.23 | 0.20 |
2023-03-31 | 0.81 | 0.27 | 0.23 |
2022-12-31 | 0.81 | 0.18 | 0.18 |
2022-09-30 | 0.82 | 0.18 | 0.18 |
2022-06-30 | 0.82 | 0.22 | 0.22 |
2022-03-31 | 0.82 | 0.21 | 0.21 |
2021-12-31 | 0.82 | 0.20 | 0.25 |
2021-09-30 | 0.83 | 0.21 | 0.21 |
2021-06-30 | 0.83 | 0.19 | 0.18 |
2021-03-31 | 0.85 | 0.21 | 0.19 |
2020-12-31 | 0.85 | 0.20 | 0.24 |
2020-09-30 | 0.84 | 0.23 | 0.24 |
2020-06-30 | 0.84 | 0.23 | 0.24 |
2020-03-31 | 0.84 | 0.23 | 0.27 |
Identifiers and Descriptors
Central Index Key (CIK) |